STEMCELL Technologies Introduces AggreWell™400 For Standardized Embryonic Stem Cell And Induced Pluripotent Stem Cell Research
Main Category: Stem Cell ResearchArticle Date: 21 Aug 2008 - 2:00 PDT
| Patient / Public: | ![]() |
5 (1 votes) |
| Healthcare Prof: | ![]() |
STEMCELL Technologies, a leader in specialty cell culture media, cell separation products and ancillary reagents for stem cell research, today announced the release of the AggreWell™400 plates, a revolutionary tool for researchers using embryonic and induced pluripotent stem cells (ESC and iPSC).
"The AggreWell™400 plate standardizes a critical step in the development of embryonic and induced pluripotent stem cells into clinically-relevant mature cells," says Clive Glover, Ph.D., STEMCELL Technologies' Product Manager for Pluripotent Stem Cell Biology. "These cells have been difficult to work with because of the lack of standardized methods to culture and differentiate them. The AggreWell™400 plate is the latest product in STEMCELL Technologies' portfolio that addresses the need for standardized methods and tools for stem cell research."
Many protocols for inducing the development ESC and iPSC into clinically relevant cell types rely on the formation of embryoid bodies (EBs), which are 3-dimensional aggregates of cells. In addition to being labor-intensive, current methods for making EBs results in aggregates that are inconsistent in size and shape, leading to inefficient differentiation.
In contrast, researchers using the AggreWell™400 plates are able to control the size of EBs, enabling them to optimize their differentiation protocols. Additionally the AggreWell™400 plates allow stem cell scientists to easily create large quantities of uniformly-sized EBs
For more information about the AggreWell™400 plates, visit here.
About STEMCELL Technologies
STEMCELL Technologies, a leader in specialty cell culture media, cell separation products and ancillary reagents for stem cell research, is a privately-owned biotechnology company based in Vancouver, Canada. Driven by science, STEMCELL Technologies delivers over 800 products to more than 70 countries worldwide including mTeSR™1, a defined, feeder-independent medium for hESC and hiPSC.
STEMCELL Technologies
Visit our stem cell research section for the latest news on this subject.
MLA
14 Feb. 2012. <http://www.medicalnewstoday.com/releases/118856.php>
APA
http://www.medicalnewstoday.com/releases/118856.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.





